Abstract: Ethyl 2-[2-(4-nitrobenzoyl)-1H-indol-3-yl]acetate was prepared in good yield and characterized by the aza-alkylation/intramolecular Michael cascade reaction of (E)-ethyl 3-[2-(tosylamino)phenyl]acrylate with 2-bromo-4 -nitroacetophenone, followed by desulfonative dehydrogenation with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) The structure of the newly synthesized compound was determined using 1 H-, 13 C-NMR, IR and mass spectral data.
Introduction
Indoles are well established as privileged scaffolds, commonly encountered in many biologically active natural products and pharmaceuticals [1] [2] [3] . More than 10,000 biologically active indole derivatives have been identified, and more than 200 derivatives are currently known as pharmaceuticals or undergoing clinical trials [4] . Among the indoles, 2-aroyl indole-3-acetic acid derivatives, which are an important subclass of 2,3-disubstituted indoles [5] , have attracted attention as a promising pro-drug for anticancer and antitumor activities [6, 7] . In continuation of our research interest in 2-aminophenyl α,β-unsaturated carbonyl compounds for the synthesis of highly functionalized indole derivatives [8] [9] [10] , we report here the preparation of a novel ethyl 2-[2-(4-nitrobenzoyl)-1H-indol-3-yl]acetate [11] [12] [13] .
The synthesis of the title compound 4 was achieved in one-pot, as presented in Scheme 1, which was performed by the aza-alkylation/intramolecular Michael cascade reaction of (E)-ethyl 3-[2-(tosylamino)phenyl]acrylate (1) with 2-bromo-4 -nitroacetophenone (2), followed by desulfonative dehydrogenation. The reaction was carried out in acetonitrile at 60 • C in the presence of triethylamine as a base and provided the indolineinter mediate 3 within 10 min. To the resulting mixture 1,8-diazabicyclo [5.4 .0]undec-7-ene (DBU) was added and gave the desired product in good yield within 20 min. The structure of compound 4 was confirmed by 1 H-and 13 C-NMR, IR, mass spectral data, and all data are in accordance with the assumed structure.
Indoles are well established as privileged scaffolds, commonly encountered in many biologically active natural products and pharmaceuticals [1] [2] [3] . More than 10,000 biologically active indole derivatives have been identified, and more than 200 derivatives are currently known as pharmaceuticals or undergoing clinical trials [4] . Among the indoles, 2-aroyl indole-3-acetic acid derivatives, which are an important subclass of 2,3-disubstituted indoles [5] , have attracted attention as a promising pro-drug for anticancer and antitumor activities [6, 7] .In continuation of our research interest in 2-aminophenyl α,β-unsaturated carbonyl compounds for the synthesis of highly functionalized indole derivatives [8] [9] [10] , we report here the preparation of a novel ethyl 2-[2-(4-nitrobenzoyl)-1H-indol-3-yl]acetate [11] [12] [13] .
The synthesis of the title compound 4 was achieved in one-pot, as presented in Scheme 1,which was performed by the aza-alkylation/intramolecular Michael cascade reaction of (E)-ethyl 3-[2-(tosylamino)phenyl]acrylate (1) with 2-bromo-4′-nitroacetophenone (2), followed by desulfonative dehydrogenation. The reaction was carried out in acetonitrile at 60 °C in the presence of triethylamine as a base and provided the indolineinter mediate 3 within 10 min. To the resulting mixture 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) was added and gave the desired product in good yield within 20 min. The structure of compound 4 was confirmed by 1 H-and 13 C-NMR, IR, mass spectral data, and all data are in accordance with the assumed structure. 
Scheme 1. Synthesis of ethyl 2-[2-(4-nitrobenzoyl)-1H-indol-3-yl]acetate (4).
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Experimental Section

General Information
All reagents were used as received without further purification. Chromatographic purification of the title compound 4 was accomplished using forced-flow chromatography on ICN 60 32-64 mesh silica gel 63 (Merck, Darmstadt, Germany). Thin-layer chromatography (TLC) (Merck, Darmstadt, Germany) was performed on EM Reagents 0.25 mm silica gel 60-F plates. Developed chromatograms werevisualized by fluorescence quenching and anisaldehyde stain. 1 H-and 13 C-NMR spectra were recorded on a 400 MHz instrument (Bruker BioSpin GmbH, Karlsruhe, Germany) as noted, and are internally referenced to residual protio solvent signals. Data for 1 H-NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), integration, coupling constant (Hz) and assignment. Data for 13 C-NMR are reported in terms of chemical shift. IR spectra were recorded on a Perkin-Elmer 1600 FT-IR spectrometer (Bruker Optics GmbH, Ettlingen, Germany), and reported in terms of frequency of absorption (cm −1 ). High-resolution mass spectrometry data were recorded on a JEOL JMS-700 MStation mass spectrometer (JEOL, Tokyo, Japan).
Syntheis of ethyl 2-[2-(4-nitrobenzoyl)-1H-indol-3-yl]acetate(4)
To a solution of (E)-ethyl 3-[2-(tosylamino)phenyl]acrylate (1, 35 mg, 0.10 mmol, 1.0 equiv) in CH 3 CN (0.5 mL), 2-bromo-4 -nitroacetophenone (2, 37 mg, 0.15 mmol) and Et 3 N (21 µL, 0.15 mmol,) were added at room temperature. After stirring the resulting mixture for 10 min at 60 • C, DBU (60 µL, 0.40 mmol) was added. The resulting mixture was stirred further for 20 min at 60 • C, and saturated aqueous NaHCO 3 was added. The mixture was then extracted with EtOAc. The combined organic layer was washed with brine, dried over anhydrous MgSO 4 , and concentrated in vacuo.The crude product waspurified on silica gel column chromatography using ethyl acetate and hexane (1/10) as eluents to afford the desired title compound 4 (89%, 31 mg 
